Peripheral arterial disease in patients with giant cell arteritis: a meta-analysis

Int J Rheum Dis. 2016 Aug;19(8):819-25. doi: 10.1111/1756-185X.12631. Epub 2015 Jul 28.

Abstract

Aim: To investigate the association between giant cell arteritis (GCA) and risk of peripheral arterial disease (PAD).

Methods: We conducted a systematic review and meta-analysis of observational cohort studies that reported relative risks, hazard ratios or standardized incidence ratios with 95% confidence comparing PAD risk in patients with GCA versus non-GCA subjects. Pooled risk ratios and 95% confidence intervals were calculated using a random-effect, generic inverse variance of DerSimonian and Laird.

Results: Four studies with 9789 patients with GCA and 236 728 controls were identified and included in our data analysis. The pooled risk ratio of PAD among patients with GCA compared with controls was 1.88 (95% CI 1.04-3.41). The statistical heterogeneity was high with an I(2) of 89%.

Conclusion: Our study demonstrated a statistically significant increased risk of PAD among patients with GCA.

Keywords: epidemiology; vasculitides (clinical aspects); vasculitides (general epidemiology studies).

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Case-Control Studies
  • Chi-Square Distribution
  • Giant Cell Arteritis / diagnosis
  • Giant Cell Arteritis / epidemiology*
  • Humans
  • Observational Studies as Topic
  • Odds Ratio
  • Peripheral Arterial Disease / diagnosis
  • Peripheral Arterial Disease / epidemiology*
  • Risk Factors